{"id":8240,"date":"2017-11-28T10:02:07","date_gmt":"2017-11-28T09:02:07","guid":{"rendered":"https:\/\/www.satt.fr\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/"},"modified":"2017-11-28T10:02:07","modified_gmt":"2017-11-28T09:02:07","slug":"parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/","title":{"rendered":"Des parasites au service de l\u2019immunit\u00e9 : lancement de la soci\u00e9t\u00e9 Par\u2019Immune accompagn\u00e9e par la SATT Nord"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Nouvelle soci\u00e9t\u00e9 biopharmaceutique lilloise d\u00e9veloppant une nouvelle th\u00e9rapie bas\u00e9e sur un parasite intestinal contre les maladies auto-immunes et inflammatoires.\u00a0<\/strong><strong>Un premier investissement de 200.000 \u20ac a \u00e9t\u00e9 annonc\u00e9 de la part de la Fondation Universit\u00e9 de Lille.<\/strong><\/p>\n<p style=\"text-align: justify;\"><!--more--><\/p>\n<p style=\"text-align: justify;\">\u00a0<\/p>\n<p style=\"text-align: justify;\">Lille, le 24 novembre 2017 \u2013 Par\u2019Immune annonce aujourd\u2019hui le lancement officiel de ses activit\u00e9s. Par\u2019Immune est une soci\u00e9t\u00e9 biopharmaceutique qui s\u2019appuie sur les r\u00e9sultats de recherches des \u00e9quipes lilloises du Pr Monique Capron qui, depuis plus de 20 ans, sont \u00e0 la pointe de la recherche mondiale en mati\u00e8re de parasitologie et d\u2019immunologie et d\u00e9veloppent des m\u00e9dicaments destin\u00e9s \u00e0 lutter contre les maladies auto-immunes et inflammatoires.<\/p>\n<p style=\"text-align: justify;\">La prot\u00e9ine issue<img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-17529 alignleft\" src=\"https:\/\/sattnord.fr\/wp-content\/uploads\/2017\/11\/PAR-IMMUNE-345x194.jpg\" alt=\"\" width=\"345\" height=\"194\" \/>\u00a0des recherches des Professeurs Andr\u00e9 et Monique Capron a un pouvoir immunomodulateur, elle a donc le pouvoir de r\u00e9guler la r\u00e9ponse immunitaire et de lutter de mani\u00e8re efficace contre les maladies auto-immunes et les maladies inflammatoires, tels que la maladie de Crohn et le psoriasis. Par\u2019Immune dispose des droits d\u2019exploitation du portefeuille de brevets pour l\u2019utilisation de la P28GST dans ces indications.<\/p>\n<p style=\"text-align: justify;\">Par\u2019Immune est d\u00e9di\u00e9e au d\u00e9veloppement de la P28GST comme candidat m\u00e9dicament innovant, d\u2019origine parasitaire. Ce candidat ciblant les maladies auto-immunes et inflammatoires est en cours d\u2019\u00e9valuation dans le cadre d\u2019un essai clinique de Phase 2a chez les patients souffrant de la maladie de Crohn.<br \/>\nL\u2019entreprise pr\u00e9voit d\u2019initier courant 2018 son plan de d\u00e9veloppement consistant \u00e0 conduire deux essais cliniques de Phase 2b dans diff\u00e9rentes maladies inflammatoires.<br \/>\nPar\u2019Immune pr\u00e9sente l\u2019originalit\u00e9 pour une jeune soci\u00e9t\u00e9 d\u2019\u00eatre d\u00e9j\u00e0 \u00e0 un stade de d\u00e9veloppement avanc\u00e9 car elle dispose d\u00e9j\u00e0 d\u2019un candidat m\u00e9dicament en phase IIa d\u2019\u00e9tudes cliniques.<br \/>\nLe lancement des activit\u00e9s de Par\u2019Immune a \u00e9t\u00e9 effectu\u00e9 le 16 novembre dernier lors d\u2019un \u00e9v\u00e8nement dans les locaux e<strong>t avec le fort soutien de la SATT Nord et de son directeur, Lionel Pujol<\/strong>\u00a0et en pr\u00e9sence de Nicolas Lebas, Vice-Pr\u00e9sident de la R\u00e9gion Hauts-de-France, d\u2019Etienne Vervaecke, directeur g\u00e9n\u00e9ral d\u2019Eurasant\u00e9, de Xavier Vandendriessche, Pr\u00e9sident de l\u2019Universit\u00e9 Droit et Sant\u00e9 de Lille (Lille\u00a02), ainsi que de nombreux acteurs lillois et parisiens, t\u00e9moignant la vigueur de l\u2019\u00e9cosyst\u00e8me lillois de recherche en sant\u00e9.<br \/>\n<strong>\u00ab Nous sommes ravis de ce premier investissement de 200.000\u20ac de la Fondation Universit\u00e9 de Lille, c\u2019est une premi\u00e8re reconnaissance du potentiel de notre strat\u00e9gie th\u00e9rapeutique et de la qualit\u00e9 du travail r\u00e9alis\u00e9 par les \u00e9quipes du Pr Monique Capron. \u00bb explique Abderrahim Lachgar, Pr\u00e9sident de Par\u2019Immune, qui ajoute \u00ab Nous travaillons actuellement pour lever des fonds importants au cours de l\u2019ann\u00e9e 2018 et ceci aupr\u00e8s d\u2019investisseurs fran\u00e7ais et internationaux avec pour objectif d\u2019acc\u00e9l\u00e9rer les recherches cliniques de phase II dans indications qui nous int\u00e9ressent . \u00bb<\/strong><\/p>\n<p style=\"text-align: justify;\">La soci\u00e9t\u00e9 Par\u2019immune est dirig\u00e9e par ses deux co-fondateurs, avec un tandem scientifiques\/managers qui est un gage de succ\u00e8s pour l\u2019avenir :<br \/>\n\u00a0 \u00a0 \u00a0\u2013 le Professeur Monique Capron, Professeur Em\u00e9rite de l\u2019Universit\u00e9 de Lille, membre de l\u2019Acad\u00e9mie nationale de Pharmacie et de l\u2019Acad\u00e9mie nationale de M\u00e9decine, Pr\u00e9sidente du Conseil d\u2019administration de l\u2019Inserm (entre 2002 et 2008), auteur de plus de 330 publications dans le domaine de l\u2019immuno-parasitologie et de l\u2019immuno-inflammation.<br \/>\n\u00a0 \u00a0 \u00a0\u2013 le Dr Abderrahim Lachgar, Docteur en Immunologie (Universit\u00e9 Paris VI) et Mast\u00e8re de management, dirigeant de plusieurs entreprises sp\u00e9cialement en Immunoth\u00e9rapie. Il a \u00e9galement coordonn\u00e9 plusieurs essais cliniques internationaux en immunoth\u00e9rapie des maladies infectieuses et du cancer.<\/p>\n<p><a href=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2017\/11\/C-P-Lancement-ParImmune.pdf\">T\u00e9l\u00e9charger le communiqu\u00e9 de presse<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nouvelle soci\u00e9t\u00e9 biopharmaceutique lilloise d\u00e9veloppant une nouvelle th\u00e9rapie bas\u00e9e sur un parasite intestinal contre les maladies auto-immunes et inflammatoires.\u00a0Un premier investissement de 200.000 \u20ac a \u00e9t\u00e9 annonc\u00e9 de la part de la Fondation Universit\u00e9 de Lille.<\/p>\n","protected":false},"author":1,"featured_media":7260,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567],"tags":[],"class_list":["post-8240","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Des parasites au service de l\u2019immunit\u00e9 : lancement de la soci\u00e9t\u00e9 Par\u2019Immune accompagn\u00e9e par la SATT Nord - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"@manager@\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/\"},\"author\":{\"name\":\"@manager@\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/58a0cf963c955da360b43eeeb4274168\"},\"headline\":\"Des parasites au service de l\u2019immunit\u00e9 : lancement de la soci\u00e9t\u00e9 Par\u2019Immune accompagn\u00e9e par la SATT Nord\",\"datePublished\":\"2017-11-28T09:02:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/\"},\"wordCount\":641,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2017\/12\/parimmune-630x350-1.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/\",\"url\":\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/\",\"name\":\"Des parasites au service de l\u2019immunit\u00e9 : lancement de la soci\u00e9t\u00e9 Par\u2019Immune accompagn\u00e9e par la SATT Nord - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2017\/12\/parimmune-630x350-1.jpg\",\"datePublished\":\"2017-11-28T09:02:07+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/58a0cf963c955da360b43eeeb4274168\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2017\/12\/parimmune-630x350-1.jpg\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2017\/12\/parimmune-630x350-1.jpg\",\"width\":630,\"height\":350},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Des parasites au service de l\u2019immunit\u00e9 : lancement de la soci\u00e9t\u00e9 Par\u2019Immune accompagn\u00e9e par la SATT Nord\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/58a0cf963c955da360b43eeeb4274168\",\"name\":\"@manager@\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/manager\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Des parasites au service de l\u2019immunit\u00e9 : lancement de la soci\u00e9t\u00e9 Par\u2019Immune accompagn\u00e9e par la SATT Nord - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/","twitter_misc":{"Written by":"@manager@","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/"},"author":{"name":"@manager@","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/58a0cf963c955da360b43eeeb4274168"},"headline":"Des parasites au service de l\u2019immunit\u00e9 : lancement de la soci\u00e9t\u00e9 Par\u2019Immune accompagn\u00e9e par la SATT Nord","datePublished":"2017-11-28T09:02:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/"},"wordCount":641,"image":{"@id":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2017\/12\/parimmune-630x350-1.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/","url":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/","name":"Des parasites au service de l\u2019immunit\u00e9 : lancement de la soci\u00e9t\u00e9 Par\u2019Immune accompagn\u00e9e par la SATT Nord - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2017\/12\/parimmune-630x350-1.jpg","datePublished":"2017-11-28T09:02:07+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/58a0cf963c955da360b43eeeb4274168"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2017\/12\/parimmune-630x350-1.jpg","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2017\/12\/parimmune-630x350-1.jpg","width":630,"height":350},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/parasites-service-de-limmunite-lancement-de-societe-parimmune-accompagnee-satt-nord\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Des parasites au service de l\u2019immunit\u00e9 : lancement de la soci\u00e9t\u00e9 Par\u2019Immune accompagn\u00e9e par la SATT Nord"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/58a0cf963c955da360b43eeeb4274168","name":"@manager@","url":"https:\/\/www.satt.fr\/en\/author\/manager\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/8240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=8240"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/8240\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/7260"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=8240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=8240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=8240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}